Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/09/2008 | CN100379349C Method for preparing immune milk anti-pathogenic microoganism in digestive tract |
04/09/2008 | CN100379341C Synergistic microbicidal combination |
04/08/2008 | US7355081 androgen receptor antagonists; certain cancers, baldness, hirsutism, behavioral disorders, acne, and inhibition of spermatogenesis if so desired |
04/08/2008 | US7355054 Indole derivatives |
04/08/2008 | US7355025 Marker molecules associated with lung tumors |
04/08/2008 | US7355016 Methods for detection of mycobacteria |
04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
04/08/2008 | US7354900 Also bactericidal or bacteriostatic contact lens coated with the peptide |
04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
04/08/2008 | US7354731 Method of screening for potential anti-bacterial agents |
04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
04/08/2008 | CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators |
04/08/2008 | CA2305013C Fusion proteins comprising hiv-1 tat and/or nef proteins |
04/08/2008 | CA2295588C Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
04/08/2008 | CA2260315C 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives, processes for their preparation and pharmaceutical compositions comprising them |
04/08/2008 | CA2220188C Vinylpyrrolidinon cephalosporin derivatives |
04/03/2008 | WO2008039420A2 Novel inhibitors of beta-lactamase |
04/03/2008 | WO2008039359A2 Bicyclic pyrimidine kinase inhibitors |
04/03/2008 | WO2008038777A1 Therapeutic agent for disseminated intravascular coagulation syndrome |
04/03/2008 | WO2008038175A2 Dithiolopyrrolones compounds and their therapeutic applications |
04/03/2008 | WO2008037880A1 New class of terpene-derived compounds having an antibiotic activity, compositions containing the same ans uses thereof |
04/03/2008 | WO2008037784A1 Quinolinone derivatives |
04/03/2008 | WO2008037482A1 Biofilm-inhibiting effect and anti-infective activity of n,c-linked arylisoquinolines and the use thereof |
04/03/2008 | WO2008037419A1 Antibodies against ccr5 and uses thereof |
04/03/2008 | WO2008037033A1 Flu vaccine admixture of mannan and flu antigen |
04/03/2008 | WO2008037011A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
04/03/2008 | WO2008022303A3 Anti-h5n1 influenza activity of the antiviral protein cyanovirin |
04/03/2008 | WO2008008776A3 Hepatitis c virus inhibitors |
04/03/2008 | WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions |
04/03/2008 | WO2007030083A3 N-(1-pyrene)maleimide, iaans and 5- (bromomethyl) fluorescein for covalent binding to md-2 and effect on the immune response |
04/03/2008 | US20080081825 5-((2,4-difluorophenyl) {[(1-methyl-4-piperidinyl)oxy]imino}methyl)-1-(2,6-dimethylphenyl)-2(1H)-pyridinone; p38 MAP kinase and tumor necrosis factor inhibitor; inflammatory cytokines or chemokine, respiratory diseases, cardiovascular diseases and bone diseases |
04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
04/03/2008 | US20080081789 Beta peptoids with antimicrobial activity |
04/03/2008 | US20080081786 Cytokine protein family |
04/03/2008 | US20080081062 Contacting medical device having surface formed from a swellable macromolecular substance with antibiotic such as isepamicin sulfate, amikacin sulfate, tobramycin, and/or kitasamycin tartrate; desolventizing |
04/03/2008 | US20080081050 Vaccine against streptococcus pneumoniae |
04/03/2008 | US20080081047 severe acute respiratory syndrome; preparing a chimeric antibody; Monoclonal antibody reagents that recognize the SARS-coronavirus (SARS-HCoV) |
04/03/2008 | CA2700218A1 Live bacterial vaccines for viral infection prophylaxis or treatment |
04/03/2008 | CA2664752A1 Antibodies against ccr5 and uses thereof |
04/03/2008 | CA2664572A1 Substituted piperidinophenyl oxazolidinones |
04/03/2008 | CA2664376A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
04/03/2008 | CA2664342A1 New chemical inhibitors of bacterial heptose synthesis, methods for their preparation and biological applications of said inhibitors |
04/03/2008 | CA2664296A1 Novel inhibitors of beta-lactamase |
04/03/2008 | CA2664124A1 New class of terpene-derived compounds having an antibiotic activity, compositions containing the same ans uses thereof |
04/03/2008 | CA2660377A1 Quinolinone derivatives |
04/02/2008 | EP1905834A2 Virulence Genes, Proteins, and their Use |
04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
04/02/2008 | EP1905831A2 Lactoferrin receptor genes of moraxella |
04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
04/02/2008 | EP1905779A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
04/02/2008 | EP1905449A2 Vaccines |
04/02/2008 | EP1905441A2 Non-sedating barbiturate compounds as neuroprotective agents |
04/02/2008 | EP1904520A2 A vaccine for staphylococcal infections |
04/02/2008 | EP1904506A1 Antiviral compounds |
04/02/2008 | EP1904501A2 Chemical compounds |
04/02/2008 | EP1904478A1 Acid addition salts of n-ethyl-n'-[2-methoxy-4-(5-methyl-4-{[(1s)-1-pyridin-3-ylbutyl]amino}pyrimidin- 2-yl)phenyl]urea and uses thereof |
04/02/2008 | EP1904096A2 Mycoplasma subunit vaccine |
04/02/2008 | EP1904083A2 Synapse-specific proteins in glomeruli |
04/02/2008 | EP1904067A2 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition |
04/02/2008 | EP1904060A1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
04/02/2008 | EP1753427B1 Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
04/02/2008 | EP1482959B1 Compositions for treatment of skin disorders |
04/02/2008 | EP1476019B1 Aqueous antiseptic based on bispyridiniumalkanes |
04/02/2008 | EP1432449B1 Water-in-oil emulsions comprising oil soluble vinyl polymers carrying acidic groups in side chains, compositions, and methods |
04/02/2008 | EP1379530A4 Process for the selective preparation of 3-(z) propenyl-cephem compound |
04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
04/02/2008 | EP1232147B1 Triazoles as farnesyl transferase inhibitors |
04/02/2008 | EP1210357B1 Oligonucleotide n3'-p5' thiophosphoramidates: their synthesis and use |
04/02/2008 | EP1129088B1 Crystalline form of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole |
04/02/2008 | EP1009824B1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
04/02/2008 | EP0822985B1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
04/02/2008 | CN101155829A High affinity HIV T cell receptors |
04/02/2008 | CN101155825A Antimicrobial hexapeptides |
04/02/2008 | CN101155816A (1, 10b-dihydro-2-(aminoalkyl- phenyl)-5h-pyraz0l0 [1,5-c] [1,3] benz0xazin-5-yl) phenyl methanone derivatives as HIV viral repliation inhibitors |
04/02/2008 | CN101155806A Oxindole oxazolidinone as antibacterial agent |
04/02/2008 | CN101155805A 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
04/02/2008 | CN101155599A Prevention of hiv-infection with tmc278 |
04/02/2008 | CN101155594A Cream loaded with shellfish firing product powder and process for producing the same |
04/02/2008 | CN101155581A Medicament and treatment for herpes simplex |
04/02/2008 | CN101153287A Streptomycete antimicrobial production and method of preparing the same |
04/02/2008 | CN101153052A Uridine peptide antibiotic, pharmaceutically acceptable salt, producing method and uses thereof |
04/02/2008 | CN101153045A Novel cephalosporin compounds |
04/02/2008 | CN101153044A Wide-spectrum antibiotic cephalosporin alkene compounds containing sulfhydryl thiazole pyridine onium methyl |
04/02/2008 | CN101153041A 1,2,3-triazole 1,3-nitrogen heterocyclic, producing method and application of the same |
04/02/2008 | CN101153001A Desmosdumotin D, synthesis of derivant thereof and application of the same in against AIDS virus |
04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
04/02/2008 | CN101152571A Vaccine wine oil adjuvant containing momordica cochinchinensis soap and method for preparing the same |
04/02/2008 | CN101152570A Epitope vaccine of hog cholera virus and its preparing process |
04/02/2008 | CN101152567A Medicament combination for regrouping human interleukin-11 |
04/02/2008 | CN101152558A New use of LSECtin |
04/02/2008 | CN101152557A Preparation of aqueous extract and zymolyte of woodlousedry powder, and application of the same in medicine |
04/02/2008 | CN101152553A Traditional Chinese medicine for treating post partum blood asthenia causing wind |
04/02/2008 | CN101152546A Externally used preparations with functions of anti-inflammation, relieving itching and sterilization disinfection, and method for preparing the same |
04/02/2008 | CN101152542A Traditional Chinese medicine for treating cholestatic hepatitis |
04/02/2008 | CN101152541A Traditional Chinese medicine for treating whooping cough |
04/02/2008 | CN101152540A Chinese traditional medicine for treating chronic hepatitis |
04/02/2008 | CN101152539A Traditional Chinese medicine for treating acute icteric hepatitis |